IRCT20220612055149N1已完成3 期
A clinical trial comparing the effect of Fenofibrate on the prognosis in hospitalized patients with COVID-19
Artesh University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Age more than 18 years
- •Confirmed diagnosis of COVID-19 with RT-PCR
- •Hospitalization
- •Symptom onset lower than 10 days
排除标准
- •Pregnancy, breastfeeding
- •Known hypersensitivity to fibrate agents
- •History of Fenofibrate treatment
- •Previous treatment with warfarin, ciclosporin, tacrolimus, and atorvastatin more than 40 milligrams (mg) daily
- •History of liver diseases, and hypothyroidism
研究者
相似试验
已完成
不适用
Comparison of therapeutic effects of Fenofibrate and Gemfibrozil on Lipid in patients with DiabetesIRCT201401096710N4Research deputy of Tabriz University of Medical Sciences60
已完成
3 期
Fenofibrate in PSCIRCT20200427047225N1Shahid Beheshti University of Medical Sciences30
尚未招募
不适用
Pilot Study – Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography (FAPI PET) in patients with metastatic castrate resistant prostate cancer.Cancer - ProstateMetastatic Prostate CancerACTRN12623000135617Mercy Radiology10
已完成
4 期
A CLINICAL TRIAL ON EFFECT OF SINGLE DOSE FENOFIBRATE AS AN ADJUNCT TO PHOTOTHERAPY IN NEONATAL JAUNDICECTRI/2023/03/050811Deepaa S94
尚未招募
Unknown
Homoeopathic management in Iron deficiency anemiaCTRI/2024/04/066513Dr Arshi